From teratocarcinomas to embryonic stem cells

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 357, Issue 1420, 2002, Pages 405-417

  Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Differentiation; Embryonal carcinoma; Embryonic stem cells; Human; Plasticity; Teratocarcinoma

Indexed keywords

MEDICINE;

ANIMAL; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION; CYTOLOGY; EMBRYO; HUMAN; METABOLISM; PATHOLOGY; REVIEW; STEM CELL; TERATOCARCINOMA;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EMBRYO; HUMANS; STEM CELLS; TERATOCARCINOMA;

EID: 0037192921     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2002.1058     Document Type: Article

References (157)

1. Hepatocytes from non-hepatic adult stem cells
2. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture
3. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro
4. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells
5. A comparative study of eight cell lines derived from human testicular teratocarcinoma
6. Cell surface antigens of a clonal human embryonal carcinoma cell line: Morphological and antigenic differentiation in culture
7. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells
8. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2: Differentiation in vivo and in vitro
9. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR)
10. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7)
11. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumors
12. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture
13. Insulin production by human embryonic stem cells
14. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulphate proteoglycan
15. The origin and migration of primordial germ cells in the mouse
16. Alkaline phosphatase isozymes as possible markers of differentiation in human teratocarcinoma cell lines
17. Alkaline phosphatase activity in mouse teratoma
18. Oligosaccharides containing fucose linked α(→) and α(→) to N-acetylglucosamine cause decompaction of mouse morale
19. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo
20. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells
21. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats
22. From marrow to brain: Expression of neuronal phenotypes in adult mice
23. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs
24. The effect of cells transferred into the mouse blastocyst on subsequent development
25. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells
26. Mutation selection and the natural history of cancer
27. Sheep cloned by nuclear transfer from a cultured cell line
28. Cloned transgenic calves produced from nonquiescent fetal fibroblasts
29. Somatic cell nuclear transfer in humans: Pronuclear and early embryonic development
30. Generalised potential of adult neural stem cells
31. Teratocarcinoma stem cells
32. Pathogenesis of testicular germ cell tumors
33. Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro
34. Experimental teratoma
35. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT
36. Tumors of the male sex organs
37. Surface antigens of human embryonic stem cells: Changes upon differentiation in culture
38. Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: Partial retention of a pluripotent phenotype
39. Treatment strategies of testicular cancer in the United States
40. The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratoma cells
41. Establishment in culture of pluripotential cells from mouse embryos
42. A multivalent lacto-n-fucopentaose III-lysylysine conjugate decompacts pre-implantation-stage mouse embryos, while the free-oligosaccharide is ineffective
43. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells
44. Retention of multiple developmental potentialities by cells of a mouse testicular teratocarcinoma during prolonged culture in vitro and their extinction upon hybridisation with cells of permanent lines
45. New human tumor cell lines
46. Skeletal myogenic potential of human and mouse neural stem cells
47. Independent regulation of H-2K and H-2D gene expression in murine teratocarcinomas somatic cell hybrids
48. Cytomegalovirus replicates in differentiated but not undifferentiated human embryonal carcinoma cells
49. Stem cell plasticity in muscle and bone marrow
50. Stage specific embryonic antigen involves α → fucosylated type 2 blood group chains
51. 'Target' cells, cellular phenotypes, and lineage fidelity in human leukaemia
52. The developmental capacity of nuclei taken from intestinal epithelial cells of feeding tadpoles
53. Transdetermination in cells
54. Differentiation of human germ cell tumor cells
55. Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfection
56. Isolation of a human teratoma cell line which expresses F9 antigen
57. F9 teratocarcinoma cells as a model for the differentiation of parietal and visceral endoderm in the mouse embryo
58. Neural transplantation of hNT neurons for Huntington's disease
59. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers
60. Hematopoietic potential of stem cells isolated from murine skeletal muscle
61. Mouse teratocarcinoma and mouse embryo
62. Tératocarcinoma de la souris: Isolement, culture, et proprieties de cellules à potentialities multiples
63. Effets de l'hexaméthylènebisacétamide sur la différenciation de cellules de carcinome embryonnaire
64. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells
65. Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma
66. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1
67. Stagespecific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells
68. Hematopoietic colony-forming cells derived from human embryonic stem cells
69. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes
70. Multipotentiality of single embryonal carcinoma cells
71. Transplanted human neurons derived from a teratocarcinoma cell line (NTERA2) mature, integrate and survive for over 1 year in the nude mouse brain
72. Transplantation of cultured human neuronal cells for patients with stroke
73. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
74. Stem cell concepts
75. Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins
76. Hemoglobin synthesis in cell hybrids formed between teratocarcinomas and Friend erythroleukemia cells
77. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line
78. Inability of mouse blastomere nuclei transfered to enucleated zygotes to support development in vitro
79. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
80. The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture
81. Differentiation of clonal lines of teratocarcinoma cells: Formation of embryoid bodies in vitro
82. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture
83. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow
84. Pluripotent teratocarcinoma-thymus somatic cell hybrids
85. Normal genetically mosaic mice produced from malignant teratocarcinoma cells
86. Clues to the aetiology of testicular germ cell tumors from descriptive epidemiology
87. Tumours of the male genital system
88. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei
89. Tératocarcinome de la souris: Différenciation en culture d'une lignée de cellules primitives à potentialities multiples
90. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3
91. Quantitiative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells
92. Multilineage differentiation from human embryonic stem cell lines
93. Pig cloning by microinjection of fetal fibroblast nuclei
94. Fate of teratocarcinoma cells injected into early mouse embryos
95. Human pluripotent stem cells: A progress report
96. Differentiation of human pluripotent teratocarcinomas stem cells induced by bone morphogenetic protein-2
97. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells
98. Bone marrow as a potential source of hepatic oval cells
99. Survival and integration of transplanted postmitotic human neurons following experimental brain injury in immunocompetent rats
100. Neoplasms, differentiations and mutations
101. The biology of testicular cancer. I. Behaviour after transplantation
102. Multilineage potential of adult human mesenchymal stem cells
103. NTERA-2 cells a human cell line which displays characteristics expected of a human committed neuronal progenitor cell
104. Pure, postmitotic, polarized human neurons derived from Ntera2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons
105. Stem cells versus stem lines
106. Developmental regulation of neurogenesis in the pluripotent human embryonal carcinoma cell line NTERA-2
107. The P blood groups
108. Presumptive neurons derived by differentiation of a human embryonal carcinoma cell line exhibit tetrodotoxin-sensitive sodium currents and the capacity for regenerative responses
109. Long-term proliferation of mouse primordial germ cells in culture
110. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro
111. Cultured cell lines from human teratomas: Windows into tumour growth and differentiation and early human development
112. Hepatocytic transcription factor expression in human; embryonal carcinoma and yolk sac carcinoma cell lines: Expression of HNF3α in models of early endodermal cell differentiation
113. Developmental potentialities and surface antigens of mouse teratocarcinomas x lymphoid cell hybrids
114. Hybrids between F9 nullipotent teratocarcinomas and thymus cells produce multidifferentiated tumors in mice
115. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells
116. The potential of muscle stem cells
117. Derivation of pluripotent stem cells from cultured human primordial germ cells
118. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells
119. Sequential activation of human HOX2 homeobox genes by retinoic acid in human embryonal carcinoma cells
120. Possible carcinoma-in-situ of the testis
121. Theoretical embryology
122. Visceral yolk sac-derived tumors
123. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1)
124. Extrauterine growth of mouse egg-cylinders results in malignant teratoma
125. Embryo-derived teratocarcinomas. I. The role of strain and gender in the control of teratocarcinogenesis
126. Embyro-derived teratocarcinoma. III. Development of tumors from teratocarcinoma-permissive and non-permissive strain embryos transplanted to F1 hybrids
127. 2+ in response to muscarinic and glutamate receptor antagonists during the differentiation of NTERA2 human embryonal carcinoma cells into neurons
128. Experimental production of testicular teratomas in mice
129. The biology of teratomas
130. Origin of testicular teratomas from primordial germ cells in mice
131. Experimental production of testicular teratomas in mice of strains 129, A/He and their F1 hybrids
132. The development of transplantable teratocarcinomas from intratesticular grafts of pre and post implantation mouse embryos
133. A description of spontaneous congenital testicular teratomas in strain 129 mice
134. Spontaneous testicular teratomas in an inbred strain of mice
135. The development of teratomas from parthenogenetically activated ovarian mouse eggs
136. Treatment strategies of testicular cancer in Europe
137. The induction of differentiation in teratocarcinomas stem cells by retinoic acid
138. Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP
139. The development of neural stem cells
140. Four new human germ cell tumor cell lines
141. Isolation of a primate embryonic stem cell line
142. Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts
143. Embryonic stem cell lines derived from human blastocysts
144. Red cell antigens P (globoside) and Luke: Identification by monoclonal antibodies defining the murine stage-specific embryonic antigens -3 and -4 (SSEA-3 and -4)
145. Induction of mcl1/EAT, Bcl-2 related gene, by retinoic acid or heat shock in the human embryonal carcinoma cells, NCR-G3
146. Full-term development of mice from enucleated oocytes injected with cumulus nuclei
147. History of teratomas
148. Viable offspring derived from fetal and adult mammalian cells
149. Feeder-free growth of undifferentiated human embryonic stem cells
150. Germline regulator element of Oct-4 specific for the totipotent cycle of embryonal cells